ENTX
Entera Bio Ltd
2.60$
-8.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| – | 0.3% | – | 84.2% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| – | -0.3% | – | 15.8% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| – | 22.0% | – | 1,905.3% | 3,516.7% | 1,464.6% | 2,673.8% | – | – | – | – | – | – | |
| – | 21.7% | – | 1,908.8% | 3,676.2% | 1,385.4% | 3,428.6% | – | – | – | – | – | – | |
| – | 43.7% | – | 3,814.0% | 7,192.9% | 2,850.0% | 6,102.4% | – | – | – | – | – | – | |
| – | -44.0% | – | -3,798.2% | -7,192.9% | -2,850.0% | -6,102.4% | – | – | – | – | – | – | |
| – | 0.7% | – | – | – | 8.5% | – | – | – | – | – | – | – | |
| – | -44.5% | – | -3,763.2% | -7,192.9% | -2,858.5% | -6,111.9% | – | – | – | – | – | – | |
| – | 46.5% | – | 0.0% | -14,385.7% | 17.1% | – | – | – | – | – | – | – | |
| – | -44.5% | – | -3,763.2% | -7,192.9% | -2,875.6% | -6,111.9% | – | – | – | – | – | – | |
| – | -43.5% | – | -3,743.9% | -7,166.7% | -2,836.6% | -6,092.9% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.